Biotech Values

[DewDiligence]

Well then, why are you so keen on pharma M&A..

Because (for the umpteenth time) leveraging the balance sheet will allow Big Pharma to increase return on equity. Increased return on equity will lead to higher dividend payments and/or higher stock prices, which in turn will produce an increased return on investment for shareholders.